Evidence map›Paper›PMID 33967121›Full record

ArticleAnnals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia2022

A Novel Approach to Extensive Clarithromycin-Resistant Mycobacterium avium Complex Pulmonary Disease.

Takeo Togo, Jun Atsumi, Miyako Hiramatsu, Kiyomi Shimoda, Kozo Morimoto, Yuji Shiraishi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takeo TogoSection of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Jun AtsumiSection of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Miyako HiramatsuSection of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Kiyomi ShimodaSection of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Kozo MorimotoSection of Respiratory Medicine, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Yuji ShiraishiSection of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.
Fukujuji Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 48-year-old woman with extensive clarithromycin-resistant Mycobacterium avium complex pulmonary disease (MAC-PD) was successfully treated by left lower lobectomy and lingulectomy following combination treatment of intravenous/inhaled amikacin plus bronchial occlusion by Endobronchial Watanabe Spigots (EWSs). A left pneumonectomy was initially indicated for removing all the lesions, but the procedure would have been barely tolerated by the patient. However, her preoperative combination treatment sufficiently reduced the lesions requiring resection to allow surgical preservation of the left upper division. This novel approach might be promising for patients with Mycobacterium avium complex lung disease whose pulmonary reserve will not allow an extensive parenchymal resection.

Indexed as

Lung DiseasesMycobacterium avium-intracellulare InfectionAnti-Bacterial AgentsClarithromycinFemaleHumansMiddle AgedMycobacterium avium ComplexTreatment OutcomeAnti-Bacterial AgentsClarithromycinamikacinbronchial occlusionclarithromycin-resistantEndobronchial Watanabe SpigotMycobacterium avium complex

Identifiers

PMID33967121
PMCPMC9763718
OpenAlexW3162313309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.